Table 3.

Adverse events during the treatment period.

AEs	Any grade	Grade 3*
	No. of patients with Aes (%)
Mucositis	5 (11.4)	0
Infection	4 (9.1)	1 (2.3)
Alanine aminotransferase elevation	4 (9.1)	0
Gastrointestinal disorder	2 (4.5)	0
Edema	2 (4.5)	0
Myalgia	2 (4.5)	0
Creatinine elevation	1 (2.3)	0
Dyspnea	1 (2.3)	0
Hyperuricemia	1 (2.3)	0
Acne	1 (2.3)	0

AEs: adverse events.

^*Adjuvant therapies were used to alleviate adverse effects.